Jane Street Group, LLC Cel Sci Corp Transaction History

Jane Street Group, LLC

  • $387 Billion
  • Q1 2025

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.05 - $1.5 $10,988 - $15,697
10,465 New
10,465 $11,000
Q1 2024

May 15, 2024
SELL
$1.63 - $3.08 $2,197 - $4,151
-1,348 Reduced 2.24%
58,879 $112,000
Q4 2023

Feb 14, 2024
BUY
$1.07 - $3.07 $64,442 - $184,896
60,227 New
60,227 $163,000
Q4 2022

Feb 14, 2023
BUY
$1.99 - $3.52 $62,068 - $109,788
31,190 New
31,190 $73,000
Q2 2022

Aug 16, 2022
SELL
$2.58 - $4.99 $88,989 - $172,115
-34,492 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$3.93 - $7.7 $489,556 - $959,181
-124,569 Reduced 78.32%
34,492 $136,000
Q4 2021

Feb 15, 2022
SELL
$7.1 - $12.82 $116,667 - $210,658
-16,432 Reduced 9.36%
159,061 $1.13 Million
Q3 2021

Nov 16, 2021
BUY
$7.64 - $12.49 $595,996 - $974,344
78,010 Added 80.02%
175,493 $1.93 Million
Q2 2021

Aug 16, 2021
BUY
$8.68 - $27.49 $40,717 - $128,955
4,691 Added 5.06%
97,483 $846,000
Q1 2021

May 18, 2021
BUY
$12.0 - $27.64 $727,536 - $1.68 Million
60,628 Added 188.5%
92,792 $1.41 Million
Q4 2020

Feb 17, 2021
SELL
$11.05 - $16.62 $127,539 - $191,828
-11,542 Reduced 26.41%
32,164 $375,000
Q2 2020

Aug 17, 2020
BUY
$9.75 - $17.6 $153,835 - $277,692
15,778 Added 56.5%
43,706 $652,000
Q2 2019

Aug 15, 2019
BUY
$3.77 - $8.67 $105,288 - $242,135
27,928 New
27,928 $234,000

Others Institutions Holding CVM

# of Institutions
65
Shares Held
7.55M
Call Options Held
73.8K
Put Options Held
106K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $9.54M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email